-
Quantifying Organelle Proximity by Super-Resolution
2026-09-24
Ren and colleagues describe a practical workflow that combines live-cell SIM or Airyscan imaging with machine-learning-based segmentation and batch image analysis to quantify organelle morphology and spatial proximity. Its main contribution is an accessible route from super-resolution images to morphology-based distance measurements, while emphasizing that proximity measurements should not be interpreted as proof of molecular contact or interaction.
-
Astrocytic GAT-3 Links Dentate Synapses and Memory
2026-09-24
The study identifies astrocytic GAT-3 as an active regulator of dentate gyrus synaptic transmission: GABA-dependent GAT-3 signaling raises astrocytic calcium and engages presynaptic GluN2B-containing NMDA receptors. Combining electrophysiology, optogenetics, imaging-related histology, and behavioral testing, the work connects this pathway to contextual fear memory while leaving important questions about its cellular steps and generality open.
-
AM251: CB1 Receptor Antagonist Workflows
2026-09-23
AM251 is a nanomolar CB1 receptor antagonist for separating receptor-dependent effects from broader endocannabinoid responses in neuronal, behavioral, metabolic, and cell-based studies. This guide translates recent pain research into practical antagonist-control designs, assay workflows, and troubleshooting strategies.
-
Drug-Sensitized Yeast for mTOR Inhibitor Discovery
2026-09-22
Breen and colleagues developed a genetically drug-sensitized Saccharomyces cerevisiae platform that detects TOR pathway inhibitors at substantially lower concentrations than wild-type yeast. The system identified TOR1-dependent activity for several reference compounds, while showing no detectable TOR-dependent growth inhibition for canagliflozin under the tested conditions, illustrating both its screening value and its interpretive boundaries.
-
How Omicron mRNA Vaccines Broaden Neutralization
2026-09-22
Wang and colleagues evaluated a sequential mRNA vaccination strategy that began with an Omicron BA.1 spike construct and was followed by two boosts encoding the original SARS-CoV-2 receptor-binding domain. The regimen produced broad neutralizing activity across Omicron subvariants and other variants of concern, offering a useful design framework for next-generation mRNA vaccine development.
-
Imatinib hydrochloride: Reliable Assay Workflows
2026-09-21
Learn how Imatinib hydrochloride, SKU A3487, can support reproducible kinase-inhibition, viability, proliferation, and phosphosignaling experiments. This scenario-based guide separates biochemical potency from cell-level response, addresses DMSO handling and controls, and explains how to interpret target-specific data responsibly.
-
From RNA to Mechanism in HFpEF Research
2026-09-21
Translational HFpEF research depends on more than detecting a transcript: it requires a reproducible path from RNA template quality to mechanistic interpretation. This article examines how the TGFBR1 study frames that challenge and how the HyperScript™ First-Strand cDNA Synthesis Kit can support structured, low-abundance, and long-transcript workflows for PCR amplification and qPCR.
-
Ruxolitinib, DRP1, and ATC Cell Death
2026-09-20
The reference study identifies a JAK1/2–STAT3–DRP1 axis that links cytokine-associated signaling to mitochondrial fission and cell fate in anaplastic thyroid carcinoma. Its findings suggest that Ruxolitinib can promote caspase-dependent apoptosis and GSDME-mediated pyroptosis by transcriptionally suppressing DRP1, while also highlighting important limits for translating these results beyond ATC models.
-
γH2AX DNA Damage Detection Kit Workflow
2026-09-19
Translate radiation-induced DNA double-strand breaks into a spatially resolved red-foci readout with a practical γH2AX immunofluorescence workflow. The assay is especially useful for comparing FLASH-RT, conventional radiotherapy, radiosensitizers, apoptosis, and DNA repair kinetics in fixed cells or tissues.
-
GS967: Cardiac Late Sodium Current Studies
2026-09-18
This scenario-driven guide explains how GS967 (SKU B5850) can improve experimental consistency in cardiac late sodium current research without being misapplied as a general viability reagent. It connects formulation, concentration selection, controls, aging models, and arrhythmia endpoints to published electrophysiology findings.
-
HCAR3 Cryo-EM Structures Reveal Agonist Selectivity
2026-09-17
The 2025 PLOS Biology study combines cryo-EM structures and cellular cAMP assays to explain how HCAR3 recognizes agonists and distinguishes them from HCAR2. Its residue-level analysis clarifies the roles of orthosteric-pocket geometry and aromatic interactions, providing a framework for receptor-aware lipid metabolism research.
-
Dabigatran for Reliable Thrombin Assays
2026-09-17
Learn how Dabigatran, SKU A4077, can help researchers control thrombin-dependent variability in coagulation and cell-based workflows. This scenario-driven guide connects biochemical potency, assay compatibility, protocol design, interpretation, and practical product selection to evidence-backed laboratory decisions.
-
OsCPK4–OsCNGC7 Loop in Rice Salt Tolerance
2026-09-17
The reference study identifies an OsCPK4–OsCNGC7 phosphorylation-centered feedback loop that couples salt perception to Ca2+ influx in rice. Its time-dependent model explains how phosphorylation activates and stabilizes OsCNGC7 during early stress, while later attenuation helps balance defense with growth recovery.
-
Triamcinolone (B1859): Practical Research Workflow Guide
2026-09-16
Triamcinolone is a synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid receptor signaling, inflammatory responses, and immunosuppression. This guide addresses solvent selection, preparation, controls, storage, and troubleshooting; the compound is not intended for diagnostic, therapeutic, or clinical use.
-
Interpreting Anticancer Drug Responses In Vitro
2026-09-15
Hannah R. Schwartz’s dissertation separates growth inhibition from actual cell killing, showing that anticancer drugs can affect proliferation and death with different magnitudes and timing. This framework supports more informative viability studies by pairing relative and fractional viability with time-resolved and orthogonal cell-death measurements.